{"id":"metronidazole-vaginal","safety":{"commonSideEffects":[{"rate":null,"effect":"Vaginal irritation or burning"},{"rate":null,"effect":"Metallic taste"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Vulvovaginal candidiasis (secondary infection)"}]},"_chembl":{"chemblId":"CHEMBL137","moleculeType":"Small molecule","molecularWeight":"171.16"},"_dailymed":{"setId":"b07f42dd-75d4-499a-984f-c06894ff3a45","title":"METRONIDAZOLE VAGINAL (METRONIDAZOLE) GEL [REMEDYREPACK INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metronidazole is reduced by anaerobic organisms to form reactive intermediates that damage DNA and inhibit nucleic acid synthesis. It is effective against anaerobic bacteria and certain protozoa. The vaginal formulation delivers the drug locally to treat vaginal infections caused by susceptible organisms.","oneSentence":"Metronidazole is a nitroimidazole antimicrobial that disrupts bacterial and protozoal DNA, leading to cell death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:59.212Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial vaginosis"},{"name":"Trichomoniasis vaginalis infection"},{"name":"Anaerobic vaginal infections"}]},"trialDetails":[{"nctId":"NCT05434104","phase":"NA","title":"The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study","status":"NOT_YET_RECRUITING","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2026-03","conditions":"Bacterial Vaginosis, Candida Vaginal","enrollment":114},{"nctId":"NCT07481955","phase":"PHASE2","title":"Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial","status":"NOT_YET_RECRUITING","sponsor":"Freya Biosciences ApS","startDate":"2026-03-16","conditions":"Bacterial Vaginosis (BV)","enrollment":120},{"nctId":"NCT07483671","phase":"PHASE2","title":"Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients","status":"NOT_YET_RECRUITING","sponsor":"Chengdu Syncor Pharmaceutical Co., Ltd.","startDate":"2026-04-15","conditions":"Bacterial Vaginosis","enrollment":80},{"nctId":"NCT07418996","phase":"PHASE2","title":"Live Double Combined Lactobacillus Capsule for Vaginal Use（IIa）","status":"COMPLETED","sponsor":"Guangdong Longchuangji Pharmaceutical Co., Ltd.","startDate":"2021-05-18","conditions":"Bacterial Vaginosis (BV)","enrollment":57},{"nctId":"NCT01722708","phase":"NA","title":"Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2012-11-01","conditions":"Abnormal Vaginal Flora, Clindamycin Vs Metronidazole, High Risk Pregnancies for Preterm Labor","enrollment":166},{"nctId":"NCT07247851","phase":"NA","title":"Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole","status":"COMPLETED","sponsor":"Ain Shams Maternity Hospital","startDate":"2024-01-10","conditions":"Bacterial Vaginosis","enrollment":100},{"nctId":"NCT04046900","phase":"PHASE1, PHASE2","title":"Vaginal Microbiota Transplant","status":"RECRUITING","sponsor":"Douglas Kwon","startDate":"2021-04-22","conditions":"Recurrent Bacterial Vaginosis","enrollment":62},{"nctId":"NCT04771728","phase":"PHASE4","title":"A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis","status":"RECRUITING","sponsor":"Peking University Shenzhen Hospital","startDate":"2020-02-01","conditions":"Bacterial Vaginosis","enrollment":140},{"nctId":"NCT06725888","phase":"NA","title":"Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis.","status":"RECRUITING","sponsor":"S.I.I.T. Srl","startDate":"2025-03-31","conditions":"Bacterial Vaginosis (BV), Recurrent Bacterial Vaginosis","enrollment":30},{"nctId":"NCT06950229","phase":"NA","title":"Povidone Iodine Versus Normal Saline in Preoperative Vaginal Cleansing Before Caesarean Section","status":"COMPLETED","sponsor":"Federal Teaching Hospital Abakaliki","startDate":"2020-10-06","conditions":"Povidone Iodine, Normal Saline, Pre-operative","enrollment":224},{"nctId":"NCT06458543","phase":"PHASE4","title":"Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age","status":"RECRUITING","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2024-06-01","conditions":"Bacterial Vaginosis","enrollment":100},{"nctId":"NCT06135974","phase":"EARLY_PHASE1","title":"Vaginal lIve Biotherapeutic RANdomized Trial","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2024-02-01","conditions":"Bacterial Vaginosis","enrollment":24},{"nctId":"NCT02795845","phase":"NA","title":"Oral Probiotics for the Treatment and Prevention of Vulvovaginal Infections in Pregnancy - Double-blind, Randomized, Placebo-controlled Study","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2016-11","conditions":"Bacterial Vaginosis and Vaginal Candidiasis At Pregnancy","enrollment":157},{"nctId":"NCT06659380","phase":"NA","title":"Probiotic Efficacy in Postmenopausal Women with Bacterial Vaginosis","status":"RECRUITING","sponsor":"Hasanuddin University","startDate":"2024-06-26","conditions":"Bacterial Vaginosis (BV), Menopause","enrollment":12},{"nctId":"NCT05788991","phase":"PHASE4","title":"Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis","status":"TERMINATED","sponsor":"Medinova AG","startDate":"2021-07-26","conditions":"Bacterial Vaginosis, Vaginal Infection, Vaginal Diseases","enrollment":151},{"nctId":"NCT06572761","phase":"PHASE3","title":"A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-09","conditions":"Previable Labour With Intact Membranes","enrollment":350},{"nctId":"NCT01020396","phase":"PHASE1, PHASE2","title":"Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-01","conditions":"Bacterial Vaginosis","enrollment":579},{"nctId":"NCT05383521","phase":"NA","title":"Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis","status":"NOT_YET_RECRUITING","sponsor":"Shangrong Fan","startDate":"2025-12-01","conditions":"Trichomonas Vaginitis","enrollment":20},{"nctId":"NCT00153517","phase":"PHASE2","title":"Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"1999-10","conditions":"Vaginosis, Bacterial, Premature Birth, Birth Weight","enrollment":126},{"nctId":"NCT06349122","phase":"PHASE4","title":"Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2024-08","conditions":"Bacterial Vaginosis, Vaginal Dysbiosis, Premature Delivery","enrollment":1292},{"nctId":"NCT04573504","phase":"PHASE4","title":"Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2020-09-23","conditions":"Vaginal Laceration During Delivery","enrollment":274},{"nctId":"NCT02392026","phase":"PHASE4","title":"Safety and Tolerability of Metronidazole Gel 1.3%","status":"COMPLETED","sponsor":"Insud Pharma","startDate":"2015-08-12","conditions":"Vaginosis, Bacterial","enrollment":60},{"nctId":"NCT03734523","phase":"","title":"Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis","status":"COMPLETED","sponsor":"Vaginal Biome Science","startDate":"2021-07-01","conditions":"Bacterial Vaginosis, Vaginal Flora Imbalance","enrollment":38},{"nctId":"NCT04478617","phase":"PHASE4","title":"PROJECT PREVENT: Metronidazole Antibiotic Per Vagina Before Hysterectomy: Is Additional Antibiotic Prophylaxis Beneficial?","status":"UNKNOWN","sponsor":"New York Medical College","startDate":"2020-07-15","conditions":"Post-Op Infection","enrollment":136},{"nctId":"NCT05783856","phase":"NA","title":"Effects of LiveSpo X-secret in Supporting Treatment of Sexually Transmitted Diseases","status":"COMPLETED","sponsor":"Anabio R&D","startDate":"2020-05-03","conditions":"Sexually Transmitted Diseases","enrollment":100},{"nctId":"NCT02042287","phase":"PHASE4","title":"Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2014-06","conditions":"Bacterial Vaginosis","enrollment":32},{"nctId":"NCT03769688","phase":"PHASE1","title":"Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2022-03","conditions":"Bacterial Vaginosis","enrollment":""},{"nctId":"NCT03894813","phase":"PHASE4","title":"Probiotics as Adjuvant Treatment for Bacterial Vaginosis","status":"COMPLETED","sponsor":"Peking University Shenzhen Hospital","startDate":"2019-03-26","conditions":"Bacterial Vaginosis","enrollment":126},{"nctId":"NCT04846361","phase":"NA","title":"Vaginal Hygiene Wash as Adjunct Treatment in Bacterial Vaginosis","status":"UNKNOWN","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2021-05","conditions":"Bacterial Vaginoses","enrollment":56},{"nctId":"NCT03099408","phase":"PHASE4","title":"Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis","status":"COMPLETED","sponsor":"Peking University Shenzhen Hospital","startDate":"2017-07-01","conditions":"Bacterial Vaginosis, Recurrence","enrollment":66},{"nctId":"NCT02308007","phase":"PHASE3","title":"Multi-Center Study of New Medications to Treat Vaginal Infections","status":"COMPLETED","sponsor":"Curatek Pharmaceuticals, LLC","startDate":"2015-06","conditions":"Vaginal Infection","enrollment":475},{"nctId":"NCT02308046","phase":"PHASE3","title":"Multi-Center Study of New Medications to Treat Vaginal Infections","status":"COMPLETED","sponsor":"Curatek Pharmaceuticals, LLC","startDate":"2015-06","conditions":"Vaginal Infection","enrollment":212},{"nctId":"NCT02308033","phase":"PHASE3","title":"Multi-Center Study of New Medications to Treat Vaginal Infections","status":"COMPLETED","sponsor":"Curatek Pharmaceuticals, LLC","startDate":"2015-06","conditions":"Vaginal Infection","enrollment":204},{"nctId":"NCT02766023","phase":"PHASE2","title":"LACTIN-V Study for Recurrent Bacterial Vaginosis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-06-03","conditions":"Bacterial Vaginosis","enrollment":228},{"nctId":"NCT00667368","phase":"PHASE3","title":"Bacterial Vaginosis Home Screening to Prevent STDs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-07-28","conditions":"Bacterial Vaginosis","enrollment":1370},{"nctId":"NCT03091777","phase":"PHASE3","title":"Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis","status":"COMPLETED","sponsor":"Balmoral Medical company","startDate":"2017-03-10","conditions":"Bacterial Vaginosis","enrollment":871},{"nctId":"NCT02430246","phase":"NA","title":"The Association Between the Transfer of Lactobacilli From the Gastrointestinal Tract to the Vagina and the Prevention / Eradication of Abnormal Vaginal Flora in High Risk Pregnancies","status":"TERMINATED","sponsor":"HaEmek Medical Center, Israel","startDate":"2016-01","conditions":"Pregnancy","enrollment":40},{"nctId":"NCT02237950","phase":"PHASE3","title":"Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)","status":"COMPLETED","sponsor":"Starpharma Pty Ltd","startDate":"2014-10-13","conditions":"Bacterial Vaginosis","enrollment":586},{"nctId":"NCT02459665","phase":"NA","title":"Rwanda Vaginal Microbiota Restoration Study","status":"COMPLETED","sponsor":"Janneke van de Wijgert","startDate":"2015-06-05","conditions":"Bacterial Vaginosis","enrollment":68},{"nctId":"NCT03917134","phase":"NA","title":"Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy","status":"UNKNOWN","sponsor":"CES University","startDate":"2019-05-01","conditions":"Hysterectomy, Cellulitis, Vaginosis","enrollment":600},{"nctId":"NCT03446443","phase":"PHASE4","title":"Honghe Fujie Lotion for the Treatment of Bacterial Vaginosis","status":"UNKNOWN","sponsor":"Dongfang Hospital Beijing University of Chinese Medicine","startDate":"2018-07-26","conditions":"Bacterial Vaginitis","enrollment":240},{"nctId":"NCT03806348","phase":"NA","title":"Early Resuturing Versus Expectant Management Following Perineal Wound Dehiscence Among Women Who Had a Vaginal Delivery","status":"UNKNOWN","sponsor":"Stockholm South General Hospital","startDate":"2018-12-12","conditions":"Wound; Perineal Rupture, Dehiscence","enrollment":140},{"nctId":"NCT02236156","phase":"PHASE3","title":"Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)","status":"COMPLETED","sponsor":"Starpharma Pty Ltd","startDate":"2014-10-03","conditions":"Bacterial Vaginosis","enrollment":637},{"nctId":"NCT01361048","phase":"PHASE2","title":"Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2011-12","conditions":"Trichomonas Vaginitis","enrollment":40},{"nctId":"NCT01347632","phase":"NA","title":"Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue","status":"COMPLETED","sponsor":"CONRAD","startDate":"2011-04","conditions":"Bacterial Vaginosis, Vaginal Discharge","enrollment":35},{"nctId":"NCT03187457","phase":"NA","title":"PreFem: \"What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?\"","status":"COMPLETED","sponsor":"Danisco","startDate":"2017-09-04","conditions":"Bacterial Vaginosis","enrollment":60},{"nctId":"NCT03134924","phase":"NA","title":"Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention \"WASH-2\"","status":"COMPLETED","sponsor":"University of Miami","startDate":"2013-05-03","conditions":"Vaginosis, Bacterial","enrollment":128},{"nctId":"NCT01287728","phase":"PHASE3","title":"The Value of Bacterial Loads by Real Time PCR in Predicting Recurrence of Abnormal Vaginal Flora After Oral Metronidazole Therapy","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2011-01","conditions":"Abnormal Vaginal Flora","enrollment":182},{"nctId":"NCT02376972","phase":"PHASE2","title":"Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis","status":"TERMINATED","sponsor":"Alfasigma S.p.A.","startDate":"2015-04","conditions":"BACTERIAL VAGINOSIS","enrollment":392},{"nctId":"NCT01335373","phase":"","title":"Observational Program Neo-Penotran® Forte","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-10","conditions":"Vaginal Candidiasis, Bacterial Vaginosis, Trichomonal Vaginitis","enrollment":13024},{"nctId":"NCT02713139","phase":"PHASE3","title":"Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.","status":"WITHDRAWN","sponsor":"Ache Laboratorios Farmaceuticos S.A.","startDate":"2013-09","conditions":"Sexual Active Women, Vaginal Discharge","enrollment":""},{"nctId":"NCT02642250","phase":"PHASE2, PHASE3","title":"Comparative Evaluation of Herbal and Allopathic Drugs for the Treatment of Chronic Diarrhea","status":"COMPLETED","sponsor":"Shifa Ul Mulk Memorial Hospital","startDate":"2015-01","conditions":"Chronic Diarrhea","enrollment":70},{"nctId":"NCT01813162","phase":"PHASE1","title":"In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-12","conditions":"HIV Prevention","enrollment":101},{"nctId":"NCT02186145","phase":"PHASE3","title":"Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections","status":"UNKNOWN","sponsor":"Marjan Industria e Comercio ltda","startDate":"2016-01","conditions":"Bacterial Vaginosis, Fungal Vaginal Infections","enrollment":160},{"nctId":"NCT02365389","phase":"PHASE2, PHASE3","title":"Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2014-05","conditions":"Vaginitis","enrollment":64},{"nctId":"NCT02185456","phase":"EARLY_PHASE1","title":"Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis","status":"UNKNOWN","sponsor":"Wayne State University","startDate":"2014-09","conditions":"Bacterial Vaginosis","enrollment":200},{"nctId":"NCT01230814","phase":"PHASE2","title":"Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-04","conditions":"Bacterial Vaginosis, Candidiasis, Trichomoniasis","enrollment":234},{"nctId":"NCT01153958","phase":"PHASE4","title":"Colposeptine for the Treatment of Bacterial Vaginosis","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2010-07","conditions":"Vaginosis, Bacterial","enrollment":133},{"nctId":"NCT00503542","phase":"EARLY_PHASE1","title":"Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network","status":"COMPLETED","sponsor":"Agency for Healthcare Research and Quality (AHRQ)","startDate":"2007-02","conditions":"Vaginitis","enrollment":46},{"nctId":"NCT01867164","phase":"PHASE3","title":"A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis","status":"COMPLETED","sponsor":"Janssen-Cilag, S.A.","startDate":"2007-12","conditions":"Vaginitis, Infectious Vaginosis","enrollment":160},{"nctId":"NCT01993524","phase":"NA","title":"Supplementation of Standard Antibiotic Therapy With Oral Probiotics for Bacterial Vaginosis","status":"COMPLETED","sponsor":"IBSS Biomed S.A.","startDate":"2009-03","conditions":"Bacterial Vaginosis, Bacterial Vaginitis","enrollment":594},{"nctId":"NCT01937650","phase":"PHASE2, PHASE3","title":"Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda","status":"COMPLETED","sponsor":"Makerere University","startDate":"2009-06","conditions":"Cervix Carcinoma","enrollment":38},{"nctId":"NCT01841411","phase":"PHASE4","title":"Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis","status":"UNKNOWN","sponsor":"Minia University","startDate":"2013-03","conditions":"Bacterial Vaginosis","enrollment":90},{"nctId":"NCT00140764","phase":"PHASE3","title":"Intravaginal Treatment of Disturbances of Vaginal Flora Among HIV Infected and Uninfected Women in Malawi","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2003-01","conditions":"Bacterial Vaginosis, Trichomonas Vaginitis, Urogenital Diseases","enrollment":""},{"nctId":"NCT01055106","phase":"PHASE2","title":"Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis","status":"COMPLETED","sponsor":"Graceway Pharmaceuticals, LLC","startDate":"2010-01","conditions":"Vaginosis, Bacterial, Vaginal Infection","enrollment":255},{"nctId":"NCT01020877","phase":"PHASE1","title":"Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2001-11","conditions":"Healthy","enrollment":38},{"nctId":"NCT00545181","phase":"NA","title":"Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial","status":"COMPLETED","sponsor":"Indiana University School of Medicine","startDate":"2007-09","conditions":"Bacterial Vaginosis","enrollment":55},{"nctId":"NCT00313131","phase":"PHASE3","title":"Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2004-01","conditions":"Bacterial Vaginosis, Candidiasis, Vaginitis","enrollment":1524}],"_emaApprovals":[],"_faersSignals":[{"count":7,"reaction":"FATIGUE"},{"count":7,"reaction":"VAGINAL DISCHARGE"},{"count":5,"reaction":"NAUSEA"},{"count":5,"reaction":"VAGINAL HAEMORRHAGE"},{"count":4,"reaction":"ABORTION SPONTANEOUS"},{"count":4,"reaction":"DRY MOUTH"},{"count":4,"reaction":"VULVOVAGINAL DISCOMFORT"},{"count":3,"reaction":"BACK PAIN"},{"count":3,"reaction":"BACTERIAL VAGINOSIS"},{"count":3,"reaction":"DIARRHOEA"}],"_approvalHistory":[],"publicationCount":50,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Metronidazole Suppositories","MetroGel","Vandazole"],"phase":"marketed","status":"active","brandName":"Metronidazole Vaginal","genericName":"Metronidazole Vaginal","companyName":"Peking University Shenzhen Hospital","companyId":"peking-university-shenzhen-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole is a nitroimidazole antimicrobial that disrupts bacterial and protozoal DNA, leading to cell death. Used for Bacterial vaginosis, Trichomoniasis vaginalis infection, Anaerobic vaginal infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}